MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 89 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $37,017,000 | -34.5% | 9,072,877 | +2.0% | 0.32% | -28.7% |
| Q3 2016 | $56,477,000 | +15.5% | 8,894,008 | -2.0% | 0.46% | +12.9% |
| Q2 2016 | $48,912,000 | -28.1% | 9,074,557 | +11.7% | 0.40% | -22.0% |
| Q1 2016 | $68,023,000 | +18.7% | 8,127,022 | +12.0% | 0.52% | +34.2% |
| Q4 2015 | $57,321,000 | +3.4% | 7,255,815 | +11.4% | 0.39% | -1.5% |
| Q3 2015 | $55,413,000 | -8.2% | 6,511,561 | +33.4% | 0.39% | +6.5% |
| Q2 2015 | $60,362,000 | +75.0% | 4,881,667 | +68.1% | 0.37% | +84.9% |
| Q1 2015 | $34,494,000 | +545.6% | 2,903,559 | +105.9% | 0.20% | +485.3% |
| Q3 2013 | $5,343,000 | -46.9% | 1,409,870 | -5.5% | 0.03% | -50.7% |
| Q2 2013 | $10,055,000 | – | 1,491,850 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |